MESSA, PIERGIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 8322
EU - Europa 7501
AS - Asia 2149
AF - Africa 183
SA - Sud America 179
OC - Oceania 134
Continente sconosciuto - Info sul continente non disponibili 11
Totale 18479
Nazione #
US - Stati Uniti d'America 8068
IT - Italia 5212
CN - Cina 1043
DE - Germania 592
GB - Regno Unito 377
FR - Francia 366
JP - Giappone 209
IN - India 192
CA - Canada 167
ES - Italia 140
AU - Australia 122
TW - Taiwan 110
ZA - Sudafrica 101
KR - Corea 89
RU - Federazione Russa 82
CH - Svizzera 73
BR - Brasile 72
MX - Messico 71
CZ - Repubblica Ceca 67
ID - Indonesia 67
TR - Turchia 66
FI - Finlandia 65
NL - Olanda 63
CL - Cile 49
IR - Iran 49
VN - Vietnam 47
TH - Thailandia 44
PL - Polonia 43
GR - Grecia 40
RO - Romania 40
SE - Svezia 40
MK - Macedonia 39
RS - Serbia 39
BE - Belgio 34
AT - Austria 25
AE - Emirati Arabi Uniti 24
IQ - Iraq 24
LK - Sri Lanka 23
PE - Perù 23
PK - Pakistan 22
UA - Ucraina 22
IE - Irlanda 21
CO - Colombia 20
HK - Hong Kong 20
SA - Arabia Saudita 20
DK - Danimarca 19
EG - Egitto 17
IL - Israele 17
PT - Portogallo 17
SD - Sudan 17
NO - Norvegia 15
LT - Lituania 14
HU - Ungheria 13
MY - Malesia 13
MA - Marocco 12
PH - Filippine 12
AR - Argentina 11
GT - Guatemala 11
NZ - Nuova Zelanda 11
SG - Singapore 10
HR - Croazia 9
NP - Nepal 9
AL - Albania 7
CY - Cipro 7
EU - Europa 7
NG - Nigeria 6
SI - Slovenia 6
SY - Repubblica araba siriana 6
UG - Uganda 6
DZ - Algeria 5
ET - Etiopia 5
JO - Giordania 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
KE - Kenya 4
SK - Slovacchia (Repubblica Slovacca) 4
CD - Congo 3
LV - Lettonia 3
ME - Montenegro 3
OM - Oman 3
BJ - Benin 2
CU - Cuba 2
KZ - Kazakistan 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
MT - Malta 2
QA - Qatar 2
TN - Tunisia 2
UZ - Uzbekistan 2
BD - Bangladesh 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
EC - Ecuador 1
GE - Georgia 1
IS - Islanda 1
JM - Giamaica 1
Totale 18466
Città #
Fairfield 1209
Houston 751
Woodbridge 702
Seattle 604
Buffalo 557
Milan 538
Ashburn 452
Santa Cruz 395
Cambridge 385
Ann Arbor 356
Wilmington 293
Rome 224
Beijing 147
Shanghai 103
Mountain View 101
San Diego 98
Southend 91
Las Vegas 82
Muizenberg 80
Guangzhou 79
Phoenix 79
Clearwater 77
Wuhan 76
Hangzhou 69
Nanjing 67
Tokyo 65
Taipei 63
Bologna 62
Ottawa 59
Helsinki 57
Duncan 52
Nürnberg 46
Los Angeles 45
Chicago 44
Dearborn 43
Milpitas 42
Torino 42
Turin 42
Palermo 40
Bari 37
Padova 37
Riva 36
Toronto 36
University Park 36
Dallas 34
New York 33
Norwalk 33
Munich 32
Jakarta 31
Catania 30
Seoul 30
Naples 29
Madrid 28
Napoli 27
San Francisco 27
Chengdu 26
Florence 26
Provo 26
Changsha 25
Gurgaon 25
Hebei 24
Shenyang 24
Dong Ket 23
Jinan 23
Bengaluru 22
Fuzhou 22
Genova 22
San Jose 22
Trieste 22
Changchun 20
Venezia 20
Chongqing 19
Mumbai 19
Sydney 19
Trento 19
Bergamo 18
Brescia 18
Cagliari 18
Easton 18
Henderson 18
Lake Forest 18
Frankfurt Am Main 17
Lima 17
Modena 17
Verona 17
Xian 17
Saint Petersburg 16
Cosenza 15
Genoa 15
Leawood 15
Barcelona 14
Brindisi 14
Hefei 14
Pisa 14
Rio Saliceto 14
San Pietro Clarenza 14
Bangkok 13
Belgrade 13
Pavia 13
Redmond 13
Totale 9671
Nome #
Iperfosfatemia in dialisi: la scelta del chelante, file dfa8b99e-415c-748b-e053-3a05fe0a3a96 2014
Tra i pazienti anziani incidenti in dialisi, lo sviluppo di malnutrizione proteico calorica è un fattore di rischio per la mortalità indipendente dal loro grado di fragilità, file dfa8b9a8-af4d-748b-e053-3a05fe0a3a96 1693
Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group, file dfa8b995-1874-748b-e053-3a05fe0a3a96 982
Nuovi scenari nell’iperparatiroidismo secondario: etelcalcetide : Position Paper dei Nefrologi lombardi [New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of Nephrologists form Lombardy], file dfa8b99b-3f9f-748b-e053-3a05fe0a3a96 724
Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients, file dfa8b99e-8719-748b-e053-3a05fe0a3a96 604
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis, file dfa8b9a4-f6a6-748b-e053-3a05fe0a3a96 471
Hepcidin levels in chronic hemodialysis patients : A critical evaluation, file dfa8b995-c518-748b-e053-3a05fe0a3a96 457
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine, file dfa8b9a0-6e94-748b-e053-3a05fe0a3a96 445
Luminex technology for anti-HLA antibody screening : evaluation of performance and of impact on laboratory routine, file dfa8b99c-0ea4-748b-e053-3a05fe0a3a96 441
La doppia borsa di tabacco intorno alla cuffia profonda del catetere peritoneale: una tecnica per l’inizio immediato della CAPD [Double purse-string craft around the inner cuff: a new technique for an immediate start of CAPD], file dfa8b9a1-7f5a-748b-e053-3a05fe0a3a96 307
Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial, file dfa8b99b-b6a5-748b-e053-3a05fe0a3a96 262
Trattamento dell’iperuricemia nel paziente nefropatico: è giunto il momento di agire?, file dfa8b99c-49a0-748b-e053-3a05fe0a3a96 259
Podocytes: Recent biomolecular developments, file dfa8b99c-19ae-748b-e053-3a05fe0a3a96 251
HBV vaccination with Fendrix is effective and safe in pre-dialysis CKD population, file dfa8b99f-17bd-748b-e053-3a05fe0a3a96 238
Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular disease, file dfa8b9a2-23ed-748b-e053-3a05fe0a3a96 221
Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study, file dfa8b99c-50fe-748b-e053-3a05fe0a3a96 218
How a skilful and motivated urinary sediment examination can save the kidneys, file dfa8b99c-342b-748b-e053-3a05fe0a3a96 217
I nuovi farmaci antivirali per la terapia di HCV post- trapianto renale, file dfa8b99c-9730-748b-e053-3a05fe0a3a96 183
The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival, file dfa8b99c-508c-748b-e053-3a05fe0a3a96 173
Fluorinated-PLGA Nanoparticles for Enhanced Drug Encapsulation and 19F-NMR Detection, file dfa8b9a2-2eff-748b-e053-3a05fe0a3a96 172
VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey, file dfa8b99b-c4e8-748b-e053-3a05fe0a3a96 169
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism, file dfa8b99b-ce40-748b-e053-3a05fe0a3a96 165
Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients, file dfa8b99b-feac-748b-e053-3a05fe0a3a96 154
Calcimimetic increases osteoprotegerin and decreases fetuin-A levels in dialysis patients, file dfa8b99c-50d7-748b-e053-3a05fe0a3a96 152
Discoidin domain receptor-1 and periostin: New players in chronic kidney disease, file dfa8b99c-3314-748b-e053-3a05fe0a3a96 146
Evaluating targets and costs of treatment for secondary hyperparathyroidism in incident dialysis patients: the FARO-2 study, file dfa8b991-8fdd-748b-e053-3a05fe0a3a96 145
A randomized study evaluating cinacalcet to treat hypercalcemia in renal transplant recipients with persistent hyperparathyroidism, file dfa8b99c-44dc-748b-e053-3a05fe0a3a96 142
Behaviour of phosphate removal with different dialysis schedules, file dfa8b99d-3bff-748b-e053-3a05fe0a3a96 140
Metabolic acidosis in renal transplantation: Neglected but of potential clinical relevance, file dfa8b99c-504f-748b-e053-3a05fe0a3a96 138
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: A secondary analysis of the EXCITE trial, file dfa8b99e-12f4-748b-e053-3a05fe0a3a96 138
A new approach for anemia in kidney disease, file dfa8b9a1-fdf9-748b-e053-3a05fe0a3a96 138
Farmaci ad azione antivirale diretta, epatite C e dialisi: un aggiornamento, file dfa8b99c-bb1c-748b-e053-3a05fe0a3a96 135
Effect of VDRA on survival in incident hemodialysis patients: results of the FARO-2 observational study, file dfa8b992-1a8a-748b-e053-3a05fe0a3a96 133
Pratica clinica per la diagnostica delle aritmie cardiache in pazienti in terapia renale sostitutiva: dati di una survey lombarda, file dfa8b999-d6be-748b-e053-3a05fe0a3a96 133
Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN), file dfa8b99b-a9ed-748b-e053-3a05fe0a3a96 132
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis, file dfa8b99b-f981-748b-e053-3a05fe0a3a96 131
The long-term outcome of 93 patients with proliferative lupus nephritis, file dfa8b99c-0ea0-748b-e053-3a05fe0a3a96 129
Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients, file dfa8b99d-58f4-748b-e053-3a05fe0a3a96 129
End-stage renal disease costs for patients new to hemodialysis in Italy: The FARO-2 Study, file dfa8b994-0740-748b-e053-3a05fe0a3a96 128
Persistent secondary hyperparathyroidism after renal transplantation, file dfa8b99d-3bf1-748b-e053-3a05fe0a3a96 128
The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients : TMPRSS6 and hepcidin in hemodialysis, file dfa8b990-fa3e-748b-e053-3a05fe0a3a96 125
Membranous Nephropathy (MN) Recurrence after Renal Transplantation, file dfa8b99e-9cd3-748b-e053-3a05fe0a3a96 122
Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: The evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial, file dfa8b9a4-caef-748b-e053-3a05fe0a3a96 122
Renal transplantation in adults with Henoch-Schonlein purpura: long-term outcome, file dfa8b99c-4dcd-748b-e053-3a05fe0a3a96 120
Vitamin K in Chronic Kidney Disease, file dfa8b99c-ac37-748b-e053-3a05fe0a3a96 119
Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations, file dfa8b999-7014-748b-e053-3a05fe0a3a96 118
FGF23 and vascular calcifications: Another piece of the puzzle?, file dfa8b99b-c859-748b-e053-3a05fe0a3a96 117
Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier, file dfa8b99c-64df-748b-e053-3a05fe0a3a96 115
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), file dfa8b996-2a80-748b-e053-3a05fe0a3a96 113
Direct in vivo assessment of parathyroid hormone-calcium relationship curve in renal patients, file dfa8b99c-edc7-748b-e053-3a05fe0a3a96 113
Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation, file dfa8b99e-fd7c-748b-e053-3a05fe0a3a96 113
Physical performance and clinical outcomes in dialysis patients: A secondary analysis of the excite trial, file dfa8b99c-1b6d-748b-e053-3a05fe0a3a96 112
Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study, file dfa8b99c-555d-748b-e053-3a05fe0a3a96 112
Impact of the method of calculation on assessment of the PTH-calcium set point, file dfa8b99d-2eb1-748b-e053-3a05fe0a3a96 112
Podocyte developmental defects caused by adriamycin in zebrafish embryos and larvae: A novel model of glomerular damage, file dfa8b994-1e28-748b-e053-3a05fe0a3a96 111
Glomerular autoimmune multicomponents of human lupus nephritis in vivo (2): Planted antigens, file dfa8b99c-3313-748b-e053-3a05fe0a3a96 111
Polymer nanoparticle engineering for podocyte repair : from in vitro models to new nanotherapeutics in kidney diseases, file dfa8b99b-e17c-748b-e053-3a05fe0a3a96 110
Hepatorenal syndrome and novel advances in its management, file dfa8b99c-6558-748b-e053-3a05fe0a3a96 109
FGF23-regulated production of Fetuin-A (AHSG) in osteocytes, file dfa8b99c-51f6-748b-e053-3a05fe0a3a96 108
FGF23 and Fetuin-A Interaction and Mesenchymal Osteogenic Transformation, file dfa8b99e-0258-748b-e053-3a05fe0a3a96 108
The long-term prognosis of renal transplant in patients with systemic vasculitis, file dfa8b99b-ce3b-748b-e053-3a05fe0a3a96 107
Skeletal fractures in patients on renal replacement therapy: How large still is the knowledge gap?, file dfa8b99c-2133-748b-e053-3a05fe0a3a96 107
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, file dfa8b9a2-30b0-748b-e053-3a05fe0a3a96 105
Nutritional vitamin D in renal transplant patients : speculations and reality, file dfa8b999-3468-748b-e053-3a05fe0a3a96 103
Recent advances on Hepatitis C virus in dialysis population, file dfa8b99c-2685-748b-e053-3a05fe0a3a96 103
NeuroD Expression in Podocytes and Interrelationships with Nephrin at Both Nuclear and Cytoplasmic Sites, file dfa8b99b-ace8-748b-e053-3a05fe0a3a96 102
Fifteen years of research on nephrin: what we still need to know, file dfa8b99b-e78a-748b-e053-3a05fe0a3a96 102
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients, file dfa8b99b-fdca-748b-e053-3a05fe0a3a96 100
Erythropoietin Use and Immunogenicity of Hepatitis B Virus Vaccine in Chronic Kidney Disease Patients: A Meta-Analysis, file dfa8b99b-a23e-748b-e053-3a05fe0a3a96 99
Functional renal involvement in normotensive patients with progressive systemic sclerosis: impaired sodium excretion during isotonic saline infusion, file dfa8b99d-0a17-748b-e053-3a05fe0a3a96 99
Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence, file dfa8b99f-d1a3-748b-e053-3a05fe0a3a96 99
FGF23 and Fetuin-A interaction in the liver and in the circulation, file dfa8b99b-a743-748b-e053-3a05fe0a3a96 98
Antiviral Therapy for HCV-Associated Cryoglobulinemic Glomerulonephritis : Case Report and Review of the Literature, file dfa8b99c-799c-748b-e053-3a05fe0a3a96 98
Rituximab therapy for primary glomerulonephritis: Report on two cases, file dfa8b99c-7a00-748b-e053-3a05fe0a3a96 98
Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology, file dfa8b9a2-e5ad-748b-e053-3a05fe0a3a96 97
Measuring and estimating GFR and treatment effect in ADPKD patients : results and implications of a longitudinal cohort study, file dfa8b99b-ad75-748b-e053-3a05fe0a3a96 94
Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?, file dfa8b99b-fc01-748b-e053-3a05fe0a3a96 94
The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy, file dfa8b99c-1b38-748b-e053-3a05fe0a3a96 93
Clinical impact of hypercalcemia in kidney transplant, file dfa8b99b-b6a6-748b-e053-3a05fe0a3a96 92
Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers, file dfa8b99d-0b4e-748b-e053-3a05fe0a3a96 92
New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology, file dfa8b9a0-a10b-748b-e053-3a05fe0a3a96 92
Novel evidence on hepatitis C virus-associated glomerular disease, file dfa8b99c-6128-748b-e053-3a05fe0a3a96 90
ERRATUM: Dietary treatment of urinary risk factors for renal stone formation : A review of CLU Working Group, file dfa8b995-f487-748b-e053-3a05fe0a3a96 89
The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis, file dfa8b9a2-3044-748b-e053-3a05fe0a3a96 89
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease, file dfa8b9a2-2f04-748b-e053-3a05fe0a3a96 87
Native Hypovitaminosis D in CKD Patients : From Experimental Evidence to Clinical Practice, file dfa8b99f-3bcd-748b-e053-3a05fe0a3a96 86
Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis, file dfa8b9a0-3cb6-748b-e053-3a05fe0a3a96 85
Kinetics of hepatitis B virus load during haemodialysis sessions and α-interferon: A prospective study, file dfa8b99c-799f-748b-e053-3a05fe0a3a96 84
Long-term evaluation of coronary artery calcifications in kidney transplanted patients : a follow up of 5 years, file dfa8b99d-ddc9-748b-e053-3a05fe0a3a96 83
Pathophysiology of Non Alcoholic Fatty Liver Disease, file dfa8b999-5f90-748b-e053-3a05fe0a3a96 80
Application of retinoic acid to obtain osteocytes cultures from primary mouse osteoblasts, file dfa8b99c-44de-748b-e053-3a05fe0a3a96 78
Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD, file dfa8b99e-b1b8-748b-e053-3a05fe0a3a96 78
Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study, file dfa8b9a4-4ab5-748b-e053-3a05fe0a3a96 65
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study, file dfa8b9a4-ac33-748b-e053-3a05fe0a3a96 55
Nuove terapie per l’epatite C nei pazienti nefropatici cronici, file dfa8b99c-20a1-748b-e053-3a05fe0a3a96 51
Correction to: Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy (Journal of Nephrology, (2020), 33, 2, (193-196), 10.1007/s40620-020-00727-y), file dfa8b9a2-2f06-748b-e053-3a05fe0a3a96 50
Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients : lessons from the first phase of the epidemics in Lombardy, file dfa8b9a2-23ea-748b-e053-3a05fe0a3a96 48
The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial, file dfa8b9a4-e9bf-748b-e053-3a05fe0a3a96 48
Fitness for entering a simple exercise program and mortality: A study corollary to the exercise introduction to enhance performance in dialysis (Excite) trial EXCITE working group, file dfa8b99c-3040-748b-e053-3a05fe0a3a96 46
Graphene quantum dots : from efficient preparation to safe renal excretion, file dfa8b9a4-5d37-748b-e053-3a05fe0a3a96 40
Totale 18833
Categoria #
all - tutte 36819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36819


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018255 0213225 1915 2029 14321731
2018/20191714 25263046 4863 15594 168278431350
2019/20203981 334246257443 350357 333382 406277297299
2020/20215116 352376311358 413529 372507 362510508518
2021/20227596 404326406634 744476 716655 6536091223750
2022/2023607 46314400 00 00 0000
Totale 19482